Silicon Laboratories (SLAB) FY2013 results: revenue $580 million, up 3.0% on the year
Silicon Laboratories Inc. (SLAB) reported revenue of $580 million for fiscal 2013, the year ended 28 December 2013, up 3.0% on the year before. Net income was $50 million, down 21.6%, and diluted earnings per share $1.14. The figures are the company's own, from the 10-K it filed with the SEC on 31 January 2014.
Revenue
$580 million
+3.0% on the year
FY2008FY2013
Operating margin
11.1%
15.2% a year earlier
FY2008FY2013
Net income
$50 million
-21.6% on the year
FY2008FY2013
Diluted EPS
$1.14
-22.4% on the year
FY2008FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
580
563
492
+3.0%
Cost of revenue
227
225
193
+0.8%
Gross profit
353
338
298
+4.4%
Gross margin
60.8%
60.0%
60.7%
Research and development
158
138
136
+14.4%
Selling, general and administrative
131
114
112
+14.3%
Operating income
64.3
85.7
50.1
-24.9%
Operating margin
11.1%
15.2%
10.2%
Interest expense
3.3
1.1
0.0
+186.6%
Pre-tax income
62.0
86.3
52.3
-28.2%
Income tax
12.2
22.8
16.9
-46.5%
Effective tax rate
19.7%
26.4%
32.2%
Net income
49.8
63.5
35.5
-21.6%
Net margin
8.6%
11.3%
7.2%
Diluted EPS
$1.14
$1.47
$0.79
-22.4%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
120
97.0
88.7
+23.8%
Capital expenditure
10.5
102
8.7
-89.7%
Free cash flow
110
-5.0
80.1
Free cash flow margin
18.9%
-0.9%
16.3%
Depreciation and amortisation
28.1
24.3
23.5
+15.5%
Share-based compensation
30.8
31.2
36.1
-1.2%
Buybacks
26.0
62.0
110
-58.0%
Diluted shares, weighted
44m
43m
45m
+1.0%
Shares outstanding at period end
43m
42m
42m
+2.1%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
739
650
599
+13.6%
Debt
95.0
100
0.0
-5.0%
Other liabilities
158
122
107
+29.2%
Total liabilities and equity
991
872
706
+13.7%
Fixed assets
132
135
25.1
-2.1%
Goodwill
229
130
115
+75.6%
Intangible assets
132
90.8
60.0
+45.0%
Investments
190
188
230
+1.2%
Cash and equivalents
95.8
105
95.0
-9.1%
Receivables
72.1
78.0
55.4
-7.6%
Inventory
45.3
49.6
34.8
-8.7%
Other assets
94.9
94.7
90.3
+0.2%
Total assets
991
872
706
+13.7%
10-K for the year ended 28 December 2013, filed 31 January 2014: the filing.